1. Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial. (July 2022) Authors: Harrison, Stephen A; Abdelmalek, Manal F; Neff, Guy; Gunn, Nadege; Guy, Cynthia D; Alkhouri, Naim; Bashir, Mustafa R; Freilich, Bradley; Kohli, Anita; Khazanchi, Arun; Sheikh, Muhammad Y; Leibowitz, Mark; Rinella, Mary E; Siddiqui, Mohammad S; Kipnes, Mark; Moussa, Sam E; Younes, Ziad H; Bansal, ... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 7(2022) Page Start: 603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dihydroxyphenylglycol as a Biomarker of Norepinephrine Transporter Inhibition by Atomoxetine: Human Model to Assess Central and Peripheral Effects of Dosing. Issue 6 (December 2016) Authors: Bieck, Peter R.; Leibowitz, Mark; Lachno, D. Richard; Ledent, Edouard; Padich, Robert; Jhee, Stan Journal: Journal of clinical psychopharmacology Issue: Volume 36:Issue 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial. Issue 7 (July 2021) Authors: Burns, Daniel K; Alexander, Robert C; Welsh-Bohmer, Kathleen A; Culp, Meredith; Chiang, Carl; O'Neil, Janet; Evans, Rebecca M; Harrigan, Patrick; Plassman, Brenda L; Burke, James R; Wu, Jingtao; Lutz, Michael W; Haneline, Stephen; Schwarz, Adam J; Schneider, Lon S; Yaffe, Kristine; Saunders, Ann ... Journal: Lancet neurology Issue: Volume 20:Issue 7(2021) Page Start: 537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗